Substantial Fraud and Abuse and Program Integrity Measures Enacted
President Obama recently signed into law the much-anticipated health care reform legislation. This legislation includes significant fraud-fighting and program integrity initiatives, including transparency requirements for pharmaceutical and medical device manufacturers, and amendments to federal enforcement tools, such as the anti-kickback statute, False Claims Act and the physician self-referral law. Providers and industry will need to consider increased rigor in their compliance programs in order to fully integrate and account for the many complex and interrelated health care fraud and abuse reform initiatives under the health care reform legislation.
Click here to read full white paper.
